Global glycobiology market to be valued USD 1,934.09 Million by 2025
Growing proteomics and
glycomics industry to drive the growth of global glycobiology market.
According to TechSci Research report, “Global Glycobiology
Market By Product (Enzymes, Instruments, Reagents and Kits), By Application
(Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology,
Others), By End User (Research Institutes, Diagnostic Centers, Hospitals,
Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others),
By Company, By Region, Forecast & Opportunities, 2025”, the global glycobiology market was valued at USD
938.76 Million and is expected to grow at a formidable rate of 13.83% during
the forecast period on account of the increasing R&D activities related to glycomics
and proteomics. Additionally, ongoing technological advancements especially in
the instrumentations and kits used in glycobiology technique coupled with the
novel product launches by the major players operating in the market is further
expected to propel the market during forecast period. Also, the use of
glycobiology in the anti-cancer drug discovery is anticipated to spur the
growth of market over the next few years. Furthermore, the use of glycomics in
the field of dermatology for studying the aging pattern of the skin is expected
to positively impact the growth of market through 2025. Also, synthesis,
differentiation and proliferation of skin can be achieved using glycobiology
thereby increasing its application in tissue architecture. However, high costs
of the instrumentation, tools or kits used in the technique make it expensive which
can hamper the growth of market during forecast period. Additionally, stringent
government policies also hinder the market growth. Moreover, the technique
requires skilled personnel to perform it and lack of such skilled people might impede
the growth of market over the next few years.
https://www.techsciresearch.com/report/glycobiology-market/4635.html
The global glycobiology
market is segmented based on product, application, end user, company, and region.
Based on by product, the market can be categorized into enzymes, instruments,
reagents, and kits. The majority of market share is covered by enzymes of about
35%.
Based on by kit, the market can be categorized into glycan
releasing kit, glycan labelling kit, glycan purification kit and others. The
glycan releasing kit segment is expected to dominate the market since these
kits are applicable for different enzymes such as glycosyltransferases,
sialyltransferases, sulfotransferases, among others that generate leaving
groups with a removable phosphate. Additionally, these kits are quantitative,
convenient and amenable to high throughput analysis. Based on application, the
market can be fragmented into drug discovery, disease diagnostics, virology,
cell biology, oncology and others. The drug discovery segment is expected to
dominate the market on account of the increasing demand for personalized
medicines. Additionally, increasing R&D activities by the major players
operating in the market and different governments around the globe for the
development of novel therapeutics is further anticipated to drive the growth of
this segment during the next five years. Based on end user, the market can be
grouped into research institutes, diagnostic centers, hospitals, clinical
laboratories, pharmaceutical & biotechnology companies and others. The research
institutes segment is expected to register highest CAGR during the forecast
period. This can be accredited to the growing demand for new drug discovery and
development especially for treatment of chronic diseases such as diabetes,
cancer, among others.
Merck & Co., Inc.,
Agilent Technologies, Inc., Thermo Fisher Scientific, New England Biolabs,
Inc., Shimadzu Corporation, Takara Bio Inc., Waters Corporation, Asparia
Glycomics S.L., Bruker Corporation, RayBiotech, Inc., Z Biotech, LLC., Chemily
Glycoscience, Dextra Laboratories Ltd., Lectenz Bio, Ludger Ltd, R&D
Systems, Inc., Glycotope GmbH, Danaher Corporation, S-BIO (subsidiary of
Sumitomo Bakelite Co. Ltd., Japan), Bio-Rad Laboratories and others are some of the leading players operating in global glycobiology market.
The companies operating in the market are using organic strategies such as product
launches, mergers and collaborations to boost their share. For instance, in June
2019, Agilent Technologies (US) launched InfinityLab LC/MSD iQ System.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4635
Customers can also
request for 10% free customization on this report.
“Asia
Pacific is expected to
register significant growth in the glycobiology market during the forecast
period, owing to the increasing funding on glycomics research, rising R&D
expenditure for drug discovery & development, among others. Additionally, increasing
number of biopharmaceutical and pharmaceutical companies in the region is
further expected to create lucrative opportunities for the market players over
the next few years.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based global management consulting firm.
“Global Glycobiology
Market By Product (Enzymes, Instruments, Reagents and Kits), By Application
(Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology,
Others), By End User (Research Institutes, Diagnostic Centers, Hospitals,
Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others),
By Company, By Region, Forecast & Opportunities, 2025”,” has evaluated the future growth potential of global glycobiology
market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in global glycobiology market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]